On June 9, Research Alom set a target price of 46,000 won for Pumtech Korea, noting that strong exports driven by indie brands and the effects of preemptive production capacity (CAPA) expansion are now materializing in earnest.


"Pumtech Korea, Biggest Beneficiary of Record Cosmetics Exports" [Click e-Stock] View original image

Kim Doyoon, a researcher at Research Alom, stated in a report released on this day, "In April and May of this year, Korea's cosmetics export values ranked first and second in history. As growth led by indie brands continues, the company, which is the nation’s number one cosmetics packaging manufacturer, is directly benefiting from this trend."


Pumtech Korea is a company specializing in plastic pump-based cosmetic containers. By internalizing all processes from mold design to injection, deposition, printing, and post-processing assembly, the company ensures stable quality and delivery times. Its main business is the pump segment, which is expected to account for 74.5% of this year’s sales, while its tube business represents 24.5%, and health functional foods account for 1.0%.


Pumtech Korea’s consolidated results for this year are estimated at 406.7 billion won in sales, up 9.3% year-on-year, and 60.6 billion won in operating profit, up 7.3% from the previous year.



Kim explained, "The growth centered on indie brands continues as new hit brands such as Celimax and Dr.Melaxin add to the volume. The company is expanding production capacity with Plant 4, which was completed in November last year, and Plant 6, scheduled for completion in the third quarter of this year, while also diversifying its business into pharmaceutical and health functional food containers."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing